Covering research analysts have taken a stance on where they see Astrazeneca PLC (NYSE:AZN) moving in the future. According to Thomson Reuters, analysts are projecting a consensus target price of $35.59 on company stock. Wall Street analysts tap into their deep knowledge of the company to help calculate future stock movement. Because of the various techniques used, analysts may have very different stock target estimates.
Sell-side analysts are able to use multiple metrics in order to help calculate target price estimates. A widely used metric is a company’s preice to earnings ratio. This calculation is derived from dividing the current share price by the projected earnings per share. Astrazeneca PLC Common Stock currently has a P/E Ratio of 27.06. Investors might also evaluate a company’s PEG or price to earnings growth ratio. The PEG ratio represents the ratio of the price to earnings to the anticipated future growth rate of the company. If a company has a PEG Ratio under one, it may be seen as undervalued. If a company has a PEG Ratio over one, it may represent that the company is overvalued. A PEG Ratio near one may be viewed as fair value. Currently, the company has a PEG Ratio of -9.16.
Looking at stock performance, company shares have recently traded $-2.83 away from the 50-day moving average of $29.20 and $-4.38 away from the 200-day moving average of $30.75. The stock has been recently noted -24.74% off of the 52-week high of 35.04 and +1.89% off of the 52-week low of 25.88. Monitoring the stock price relative to moving averages and highs and lows for the year may help evaluate the value of the stock in the future.